Cinisello Balsamo, Italy

Flavio Somenzi


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Flavio Somenzi: Innovator in Pharmaceutical Chemistry

Introduction

Flavio Somenzi is a notable inventor based in Cinisello Balsamo, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his expertise and creativity in the industry.

Latest Patents

Somenzi holds 2 patents, with his latest inventions focusing on the preparation of symmetrical diacylhydrazines. This process involves a detailed methodology for synthesizing compounds that have potential applications in various therapeutic areas. Additionally, he has developed analogues of the active metabolite of leflunomide, which are recognized for their immunosuppressive and anti-inflammatory properties.

Career Highlights

Throughout his career, Flavio Somenzi has worked with prominent companies in the pharmaceutical sector, including Italfarmaco Spa and Great Lakes Chemical (Europe) GmbH. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Somenzi has collaborated with esteemed colleagues such as Giorgio Bertolini and Mauro Biffi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Flavio Somenzi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…